Testing a nutrient supplement for energy problems in septic shock
Part of Hormones & metabolism, Infections clinical trials.
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be in the ICU at Angers University Hospital
- Have septic shock, including ongoing low blood pressure needing vasopressors and a high lactate level despite enough IV fluids
- Not have a known (preexisting) mitochondrial disease
- Not be pregnant (or currently giving birth)
- Not be under legal protection, an unwilling participant, or have aplasia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
This study looks at how the body uses energy (metabolism) in people with septic shock. It collects information from standard monitoring during a fluid challenge (a small IV fluid test) to find patterns that might help doctors better understand and treat septic shock.
This study checks if a simple blood test (the ratio of urea to creatinine) can help doctors understand changes in your metabolism during septic shock. It compares this test to a more detailed measurement of how your body uses energy. This might help guide your treatment without extra invasive procedures.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.